Marketers using personal Medicare under investigation

A new investigation examining how marketers are getting the personal Medicare information of seniors is underway, with government watchdogs wanting to know if a misuse of a government system is to blame, the Associated Press reported.

The probe will be formally announced in the coming week, but was confirmed by HHS to the AP and is part of a narrower probe into a system used that verifies Medicare coverage for pharmacies. That system was potentially being used inappropriately for marketing reasons, the AP reported. The audit looked into 30 pharmacies and service providers that often leveraged the Medicare system for drugstores.

While the electronic transactions of the system are meant to be used for prescriptions, tens of thousands of queries––an average of 98%––submitted by pharmacies weren’t able to be matched to prescriptions in the audit. Four pharmacies audited also allowed marketing companies “to use their provider numbers to ping Medicare,” the AP reported, putting patient information and privacy at risk. Investigators want to look into other potential for fraud.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.